Cancer treatment & care in Bangladesh

Cancer treatment in Bangladesh is in a nascent stage. Bangladesh, a South Asian nation situated toward the east of India on the Bay of Bengal, has a populace of 156 million. With 1,074 individuals for each square kilometer, Bangladesh is additionally a standout among the most thickly populated nations.
Cancer is the sixth driving reason for death and records for 10% of all mortality in Bangladesh. In view of two emergency clinic based malignant growth vaults, about 66% of patients with disease are evaluated to be inside the age section of 30 to 65 years and establish the fundamental workforce structure in the nation.
Breast cancer, esophageal, and cervical cancer are the most well-known malignancies by rate in Bangladesh. Be that as it may, esophageal, lung, and pharyngeal malignant growths represent the most elevated rates of disease related mortality. The occurrence of diseases is required to ascend from 136,719 cases in 2015 to 250,726 cases in 2035. Lung disease is the most widely recognized cancer growth in men in Bangladesh, and 48.3% of men smoke tobacco. With tobacco being a standout among the most vital modifiable disease chance elements.
Breast cancer growth is the most well-known disease in ladies in Bangladesh. In spite of this reality, the most fundamental preventive administrations (bosom palpation) are not all around accessible at the essentially human services level. Nonetheless, endeavors are in progress to enhance training and mindfulness on self-bosom examination. With a high rate and mortality from esophageal and pharyngeal malignancies, instructive endeavors on mouth self-examination are likewise in progress.

Cancer treatment in Bangladesh

Due to severe scarcity of trained oncologists and radio therapy specialists in Bangladesh most of the patients look to visit India for cancer treatment. Kolkata being very close to Bangladesh most of the patients land in Kolkata for cancer treatment. Kolkata is home to some of the finest cancer doctors and hospitals. Hospitals in Kolkata are equipped with world class technology to overcome any kind of cancer.
CancerFax Cancer Helpline in India helps cancer patients get the best yet most economical cancer treatment in India.

For cancer treatment and surgery connect with us at +91 96 1588 1588​. Or email your reports at info@cancerfax.com for free consultation.

Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.

Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.

Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.

Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.

These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.

Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.

  • Comments Closed
  • February 5th, 2019

Patient from Somalia came to India for liver cancer treatment

Previous Post:
nxt-post

New developments in the treatment of breast cancer

Next Post:

Scan the code